In this exclusive interview with MassDevice, Intuitive Surgical president & CEO Gary Guthart weighs in on shifts in the prostate surgery conversation and recent controversies over the benefits of testing and aggressive prostate cancer treatment.
The increasingly heated conversation around the proper role of prostate cancer testing has played a big part in dragging down the market, which in turn has taken a toll on Intuitive's numbers. But the debate can be framed rather simply from a patient perspective.
"I would rather know than not know," Guthart told MassDevice.com during an exclusive meeting at the medical device company's Sunnyvale, Calif., headquarters yesterday. "The hear no evil, see no evil, see no evil strategy doesn't seem like a healthcare strategy to me."